NCT04298125 Community Translation of the Expecting Study
| NCT ID | NCT04298125 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arkansas Children's Hospital Research Institute |
| Condition | Pregnancy Related |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2021-07-16 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2021-07-16 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Expecting intervention as delivered in prior studies in a clinical setting is described in a previous approved IRB submission (Protocol 202954). The current project will seek to engage community stakeholders to translate Expecting to a community-delivered intervention and to test its acceptability, feasibility, and fidelity in a proof of principle study with 60 expecting mothers.
Eligibility Criteria
Inclusion Criteria: * (a) Body Mass Index \> 30, * (b) singleton pregnancy, * (c) between 11-15 weeks of pregnancy (at enrollment), * (d) Do not currently meet recommended guidelines of 150 min of activity per week * (e) cleared by physician Exclusion Criteria: * (a) contraindications for exercise (preeclampsia-eclampsia, premature rupture of the membranes, antepartum hemorrhage, placenta previa, multiple gestation and other defined conditions) * (b) illicit drug use.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04298125 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04298125 currently recruiting?
Yes, NCT04298125 is actively recruiting participants. Contact the research team at tswindle@uams.edu for enrollment information.
Where is the NCT04298125 trial being conducted?
This trial is being conducted at Little Rock, United States.
Who is sponsoring the NCT04298125 clinical trial?
NCT04298125 is sponsored by Arkansas Children's Hospital Research Institute. The trial plans to enroll 60 participants.